Arizona Just Put Settlement Money Behind the Naloxone Gap Washington Keeps Threatening
A rural naloxone grant program shows what happens when overdose-reversal funding sits outside the federal discretionary fights.
If you live in rural Arizona and you overdose, the nearest naloxone kit can be a genuine drive away, not a walk. That’s the gap AHCCCS is trying to close with money the federal funding chaos can’t reach.
A dollar of opioid settlement money spends differently than a dollar of federal discretionary grant money, because nobody can send Arizona a one-line termination letter and take it back overnight.
On July 10, AHCCCS released the Request for Grant Applications for its Opioid Antagonist Distribution Initiative, aimed at expanding access to naloxone and other opioid antagonists across underserved and rural parts of the state — funding distribution networks, provider training, and emergency response coordination. A pre-application conference ran July 17 for organizations weighing whether to apply. This isn’t a pilot program dressed up as a headline: it’s one piece of the up to $1.215 billion Arizona is due to receive over 18 years under the One Arizona Agreement, the state’s share of the national opioid settlements with distributors and manufacturers.
The reason this is worth separating from every other funding story this week is jurisdictional, not sentimental. Settlement dollars come from a legal judgment, not an annual appropriations fight — no HHS discretionary-award memo can zero them out, and no executive order aimed at SAMHSA grants touches them. When a federal naloxone training line gets proposed for cuts, as it periodically has been, settlement money is the backstop that doesn’t move with the political weather in Washington. Arizona choosing to route a chunk of it specifically at rural naloxone access — the geography where a reversal kit’s travel time can be the actual difference between an overdose and a death — is a deliberate bet that this money should go where federal money is least reliable.
For case managers and facility staff working rural counties: this is the grant cycle to watch if your naloxone supply chain has ever depended on a federal pass-through that got paused mid-quarter. Settlement-funded distribution networks are being built specifically so that dependency stops being a single point of failure. If your program isn’t in AHCCCS’s applicant pool for this initiative, that’s worth raising at your next team meeting — not as a maybe, as a deadline.
Sources Cited
- 01.A
- 02.AArizona — National Opioids SettlementNational Opioids Settlement
Filed Under
policytreatmentArizonaNaloxoneOpioid Settlement
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Overdose Deaths Fell Nationwide in 2025. Arizona Went the Other Way.
Overdose deaths fell about 14% nationally in 2025 but rose roughly 18% in Arizona, with fentanyl, methamphetamine and cocaine all up. What that means for naloxone, intake and settlement spending.
Arizona WatchArizona's September Naloxone Shipments Help, But They're Sized for a Crisis That's Shrinking Everywhere Except Here
Arizona is receiving 6,599 units of naloxone from Hikma and the first installment of a 33,714-unit Amneal shipment this September, under national opioid settlement deals. It's not enough given the state's rising overdose death toll.
Arizona WatchArizona Quietly Stopped Fighting Fentanyl. It's Chasing Landscapers Instead.
CBP data shows Arizona drug seizures collapsed from 27,000 to about 10,000 in three years. A DHS watchdog says it's because ICE redirected fentanyl investigators to immigration sweeps. Arizona's AG calls it a betrayal.